Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical haemocoagulase vs tranexamic acid in primary total hip arthroplasty
ChiCTR2500104916Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2025
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of batroxobin and tranexamic acid in None (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Total blood loss. Started Jun 2025; status: recruiting.
02
Drugs
batroxobintranexamic acid
Beyond the preview
Go deeper on ChiCTR2500104916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104916.